| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 833,728,170 | 842,880,387 | -1.085 | 721,601,089 | 15.538 |
| Gross Profit (Loss) | 372,598,003 | 350,539,320 | 6.292 | 330,344,397 | 12.79 |
| Operational Profit (Loss) | 189,301,115 | 168,460,082 | 12.371 | 161,828,003 | 16.976 |
| Net profit (Loss) | 171,871,096 | 149,741,384 | 14.778 | 131,438,601 | 30.761 |
| Total Comprehensive Income | 176,723,126 | 154,238,486 | 14.577 | 135,101,688 | 30.807 |
| All figures are in (Actual) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Total Shareholders Equity (after Deducting Minority Equity) | 2,700,529,204 | 2,282,141,098 | 18.333 |
| Profit (Loss) per Share | 2.15 | 1.87 | |
| All figures are in (Actual) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | – | – | |
| All figures are in (Actual) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is | Sales decreases in general due to:
Decrease in Sales in the following sectors: a) Steel industry b) Other (comparative period included sales from discontinued operation of Astra Mining) |
| The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is | Net profit Increases in general due to:
1. Increase in Gross Profit in Pharmaceuticals sector. 2. Decrease in finance costs in the following sector: A. Specialty chemical. B. Other. |
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is | Sales increases in general due to:
Increase in Sales in the following sectors: a) Pharmaceuticals. b) Steel industry. |
| The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is | Net profit Increases in general due to:
1. Increase Gross Profit in the Pharmaceuticals sector. 2. Decrease in finance costs in following sectors: A. Specialty chemical. B. Other. |
| Statement of the type of external auditor’s report | Unmodified conclusion |
| Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) | N\A |
| Reclassification of Comparison Items | Certain comparative figures for the previous period have been reclassified to be consistent with the presentation of the current period. |
| Additional Information | – Net Shareholders’ Equity at the end of the period was SR 2,707,857,633/- compared to SR 2,284,974,052/- at the end of the similar period last year with an increase of 19%. |